TELO – telomir pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TELO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/31

12:31 pm

telo

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1 [TheStreet.com]

Medium Report

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1 [TheStreet.com]

Report

3/20

08:07 am

telo

Telomir Pharmaceuticals (TELO) was upgraded by Zacks Research to "hold".

Low Report

Telomir Pharmaceuticals (TELO) was upgraded by Zacks Research to "hold".

Report

2/21

02:04 am

telo

Telomir Pharmaceuticals (NASDAQ:TELO) was upgraded by analysts at Wall S

Low Report

Telomir Pharmaceuticals (NASDAQ:TELO) was upgraded by analysts at Wall S

Report

1/24

05:10 am

telo

Telomir Pharmaceuticals (NASDAQ:TELO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Telomir Pharmaceuticals (NASDAQ:TELO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.